Roivant Sciences (ROIV) Earnings Analysis
Roivant Sciences (ROIV) next reports earnings on 2026-08-10, consensus EPS -0.33 USD. Last quarter (2026-05-20) it beat with EPS -0.2792 USD vs -0.28931 USD est (+3.5%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -77.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ROIV next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.33 USD |
| Revenue estimate | 0.00B |
ROIV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-20 | -0.2792 USD | -0.28931 USD | +3.5% | Beat |
| 2026-02-06 | -0.24 USD | -0.29954 USD | +19.9% | Beat |
| 2025-11-10 | -0.20193 USD | -0.3198 USD | +36.9% | Beat |
| 2025-08-11 | -0.25175 USD | -0.2497 USD | -0.8% | Miss |
| 2025-05-29 | -0.29 USD | -0.26351 USD | -10.1% | Miss |
| 2025-02-10 | -0.13 USD | -0.25286 USD | +48.6% | Beat |
| 2024-11-11 | -0.29 USD | -0.247 USD | -17.4% | Miss |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
ROIV valuation and analyst view
| Trailing P/E | -77.58 |
|---|---|
| Trailing EPS | -0.42694 USD |
| Price / book | 5.41 |
| Dividend yield | 0.00% |
| Market cap | 24.96B |
| Analyst consensus | Buy (14 buy / 1 hold / 0 sell) |
| Avg price target | 39.67 USD |
Related research pages
Frequently asked questions
When is Roivant Sciences (ROIV)'s next earnings date?
Roivant Sciences is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.33 USD and revenue estimate of 0.00B.
Did ROIV beat earnings last quarter?
In its 2026-05-20 report, ROIV posted EPS of -0.2792 USD versus a -0.28931 USD estimate — a beat of 3.5%.
What is ROIV's earnings track record?
Over the last 7 reported quarters with consensus data, ROIV beat estimates 4 times (57%).
What is ROIV's current P/E ratio and EPS?
ROIV trades at a trailing P/E of -77.58 on trailing EPS of -0.42694390241598656 USD.
What do analysts rate ROIV?
Analyst consensus is "Buy" across 15 ratings (0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 39.67 USD.